Overview
Status
Active
Registry date
2019-02-20
Share capital
5 000,00 PLN
Registered address
ul. Puławska 12/3, 02-566 Warszawa, Poland
Electronic delivery address
AE:PL-88974-62364-BIVUT-23
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 5.88mMedianUSD 38.54kAverageUSD 2.32m
Net profit
This companyUSD 447.84kMedianUSD -1.56kAverageUSD -88.44k
Operating costs
This companyUSD 5.28mMedianUSD 56.03kAverageUSD 2.29m
Assets
This companyUSD 2.06mMedianUSD 119.99kAverageUSD 2.73m
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-03-14. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Boris Gorišek – President of the Management Board
Wojciech Paweł Raczyński – Czlonek Zarządu
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Geneplanet, Osebna Genetika, D.o.o. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| BiotechnaS.A. | $2,472,888.07 | bsbiotechna.com | ||
| SkinlabP.S.A. | $2,218,926.75 | skinlab.pl | ||
| Enamine Plsp. z o.o. | $2,211,905.05 | enamine.net | ||
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Medict Institute Opinie Lekarskie Orzeczeniasp. z o.o. | $2,070,036.21 | medictinstitute.pl | ||
| Proteon PharmaceuticalsS.A. | $2,026,826.52 | proteonpharmaspolkaakcyjna.pl | ||
| Gravidasp. z o.o. | $1,938,646.14 | gravida.com.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| WPD Pharmaceuticalssp. z o.o. | $919,175.63 | wpdpharmaceuticals.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-08-26 | Address change (Ul. Huculska 6/Domofon 5, 00-730, Warszawa → Ul. Puławska 12/3, 02-566, Warszawa) | |
| 2020-05-21 | Address change (Ul. Puławska 12/3, 02-566, Warszawa → Ul. Huculska 6/Domofon 5, 00-730, Warszawa) | |
| 2019-02-20 | Entered in the register |
FAQ
The main business activity of Gene Planet Poland focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on February 20, 2019.
The headquarters is located at: ul. Puławska 12/3, 02-566 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 5,876,597, representing an increase of 118.9% compared to 2024.
Yes, the company recorded a net profit of USD 447,841 in 2025, meaning the company increased its profit by 871.5%.
The largest operating cost category falls under external services. This category amounted to USD 4,456,215 in 2025, representing 84% of all operating expenses.
Last updated: 2026-10-14
